Senate Committee on Health and Human Services

Policy
March 26, 2019
  • Twitter
  • Facebook
  • Google+
  • Linkedin
The Committee met on March 26 to consider the following: SB 1233 Kolkhorst, Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee. SB 1564 West, Relating to access to medication-assisted treatment for opioid use disorder under Medicaid. SB 1947 Watson, Relating to monitoring the ordering and distribution of controlled substances by veterinarians. SB 2150 Kolkhorst, Relating to the reporting of certain information on maternal mortality to the Department of State Health Services. SB 2151 Kolkhorst, Relating to the Texas Diabetes Council and the state plan for diabetes and obesity treatment and education. NEW BUSINESS SB 1233 Kolkhorst Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee. LBB Fiscal Note Summary. Estimated Two-year Net Impact to General Revenue Related Funds for SB1233, As Introduced: an impact of $0 through the biennium ending August

Subscribe to gain full access to all of our must-have reports and videos

OR

Log in